Publication | Closed Access

Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat

InflammationFibrosisHepatologyCandesartan CilexetilMedicineLiver PhysiologyPathologyHepatology InflammationHepatotoxicityLiver DiseaseHepatology FibrosisFatty Liver DiseaseHepatic Fibrosis DevelopmentPharmacologyAnti-fibrogenic EffectsDrug-induced Liver Injury